FAM120AOS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.376400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.276800E-01
Normal-vs-Stage2
6.454200E-01
Normal-vs-Stage3
1.829760E-01
Normal-vs-Stage4
9.427600E-02
Stage1-vs-Stage2
6.611800E-01
Stage1-vs-Stage3
7.808000E-02
Stage1-vs-Stage4
2.490000E-02
Stage2-vs-Stage3
7.156000E-02
Stage2-vs-Stage4
1.877660E-03
Stage3-vs-Stage4
1.928070E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.564200E-01
Normal-vs-AfricanAmerican
9.804400E-01
Normal-vs-Asian
4.821400E-01
Caucasian-vs-AfricanAmerican
5.133600E-01
Caucasian-vs-Asian
7.405200E-01
AfricanAmerican-vs-Asian
3.670800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.328800E-01
Normal-vs-Female
6.596600E-01
Male-vs-Female
9.114800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.809600E-01
Normal-vs-Age(41-60Yrs)
3.205800E-01
Normal-vs-Age(61-80Yrs)
7.735000E-01
Normal-vs-Age(81-100Yrs)
9.584800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.316200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.505400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.514000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.253600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.257300E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.385400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.906400E-01
Normal-vs-Daily Drinker
8.625000E-01
Normal-vs-Weekly Drinker
8.790000E-01
Normal-vs-Occasional Drinker
4.594000E-01
Normal-vs-Social Drinker
2.268800E-01
Non Drinker-vs-Daily Drinker
5.108400E-01
Non Drinker-vs-Weekly Drinker
5.789600E-01
Non Drinker-vs-Occasional Drinker
6.809500E-02
Non Drinker-vs-Social Drinker
1.680260E-02
Daily Drinker-vs-Weekly Drinker
9.891400E-01
Daily Drinker-vs-Occasional Drinker
1.655630E-01
Daily Drinker-vs-Social Drinker
8.973500E-02
Weekly Drinker-vs-Occasional Drinker
2.382000E-01
Weekly Drinker-vs-Social Drinker
1.611780E-01
Occasional Drinker-vs-Social Drinker
8.681600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.026000E-02
Normal-vs-Grade 2
9.341100E-03
Normal-vs-Grade 3
8.138600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.427570E-01
Grade 1-vs-Grade 3
6.443400E-01
Grade 1-vs-Grade 4
8.026000E-02
Grade 2-vs-Grade 3
2.242400E-01
Grade 2-vs-Grade 4
9.341100E-03
Grade 3-vs-Grade 4
8.138600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.415400E-01
Normal-vs-NonDiabetic
5.896600E-01
Diabetic-vs-NonDiabetic
1.345820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.990600E-01
Normal-vs-NoPancreatitis
6.458400E-01
Pancreatitis-vs-NoPancreatitis
7.111800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.263600E-01
Normal-vs-N1
6.448800E-01
N0-vs-N1
8.834000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.592800E-01
Normal-vs-TP53-NonMutant
5.739000E-01
TP53-Mutant-vs-TP53-NonMutant
1.794370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
